Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Biomx Ltd (PHGE)

7.54   -0.53 (-6.57%) 03-05 09:16
Open: 8.03 Pre. Close: 8.07
High: 8.03 Low: 7.35
Volume: 42,350 Market Cap: 175M
BiomX Inc., formerly Chardan Healthcare Acquisition Corp., is a microbiome company. The Company is focused on developing both natural and engineered phage therapies. It develops therapies to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC) and cancer. The Company discovers and validates bacterial targets and customizes phage compositions against the targets. Its pipeline includes BX001, BX002 and BX003. BX001 is a product candidate that improves the appearance of acne-prone skin. BX002 is a customized phage cocktail that eradicates bacterial targets associated with the onset of IBD. BX003 is a customized phage cocktail developed against specific strains of Klebsiella pneumoniae (Kp).

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 8.033 - 8.087 8.087 - 8.132
Low: 7.253 - 7.302 7.302 - 7.343
Close: 7.466 - 7.548 7.548 - 7.616

Technical analysis

as of: 2021-03-05 8:51:02 AM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 9.36     One year: 10.57
Support: Support1: 6.34    Support2: 5.27
Resistance: Resistance1: 8.01    Resistance2: 9.05
Pivot: 7.67
Moving Average: MA(5): 7.86     MA(20): 7.47
MA(100): 6.47     MA(250): 6.24
MACD: MACD(12,26): 0.32     Signal(9): 0.32
Stochastic oscillator: %K(14,3): 55.61     %D(3): 56.52
RSI: RSI(14): 51.75
52-week: High: 10.65  Low: 4.52  Change(%): -23.7
Average Vol(K): 3-Month: 6292  10-Days: 11452

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
PHGE has closed above bottom band by 43.5%. Bollinger Bands are 112.3% wider than normal. The large width of the bands suggest high volatility as compared to PHGE's normal range. The bands have been in this wide range for 11 bars. This is a sign that the current trend might continue.

Headline News

Tue, 02 Mar 2021
What is the Market's View on Biomx Inc (PHGE) Stock's Price and Volume Trends Tuesday? - InvestorsObserver

Tue, 02 Mar 2021
BiomX Announces Dosing of First Subject in Phase 2 Study of BX001 for Acne-Prone Skin - Business Wire

Mon, 01 Mar 2021
BiomX to Present at Upcoming March Investor Conferences - Business Wire

Mon, 22 Feb 2021
Biomx Inc (PHGE) Stock:Do Analysts Think You Should Buy? - InvestorsObserver

Mon, 22 Feb 2021
BiomX Inc.: Clinical Stage Phage Therapeutics Company Looks Promising - Seeking Alpha

Tue, 16 Feb 2021
Do Analysts Expect Biomx Inc (PHGE) Stock to Rise? - InvestorsObserver

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  AMEX
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 23
Shares Float (M) 15
% Held by Insiders 18.25
% Held by Institutions 26.24
Shares Short (K) 23
Shares Short P. Month (K) 28

Stock Financials

EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin
Return on Assets (ttm) -27.9
Return on Equity (ttm) -46.0
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.141
Qtrly Earnings Growth
Operating Cash Flow (M) -23
Levered Free Cash Flow (M) -16

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow -7.57

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.